WalkMe is a cloud-based Digital Adoption Platform enabling organizations to effectively accelerate Coupa user adoption, measure digital transformations, and quickly achieve software ROI.
Acquis can implement your customized WalkMe solutions to deliver real-time enduser training, drive engagement, maximize productivity and gather insights on your organization’s usage of Coupa.
Automate User Onboarding
Create Smart Walk-thrus
Interactive Action Bots
Increase Coupa Adoption
Drive Self-Service Support
Increase Compliance
Acquis leverages years of spend and expense management experience to support our clients with successful Coupa deployment. With a focus on achieving a rapid ROI, Acquis follows rigorous standard deployment methodologies. We also understand many clients appreciate additional consulting and assistance developing their procurement policies. Acquis is agile to support all of our clients’ needs and understands while we have a standard tool, each client will approach the deployment with their unique definition of success.
Subscribe to the Acquis newsletter
Tags:
Acquis partnered with Cara Collective for its recent IRL to answer the question benefits leaders have asked for years: why do frontline workers let employer benefits go unused?
Read More
Senior leaders have moved quickly to put AI into their workforces. Now, they face the harder work of deciding what AI should change and how to prove its value.
Read More
Geopolitical disruption has become a standing risk for drugmakers. It calls for a standing response: a resilient, adaptable operating model built to withstand these fault lines and pressure points.
Read More
Acquis partnered with Cara Collective for its recent IRL to answer the question benefits leaders have asked for years: why do frontline workers let employer benefits go unused?
Read More
Senior leaders have moved quickly to put AI into their workforces. Now, they face the harder work of deciding what AI should change and how to prove its value.
Read More
Geopolitical disruption has become a standing risk for drugmakers. It calls for a standing response: a resilient, adaptable operating model built to withstand these fault lines and pressure points.
Read More
